Canopy Rivers’ joint venture awarded Health Canada cultivation license
Category: #health  | By Mateen Dalal  | Date: 2019-07-23 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Canopy Rivers’ joint venture awarded Health Canada cultivation license

PharmHouse’s greenhouse facility in Ontario is reportedly one of the largest in the world

Canopy Rivers Inc, Canopy Growth Corp’s venture capital arm, has recently announced that its PharmHouse Joint venture has secured a license for cultivation from health Canada.

According to reports, Canopy Rivers owns 49% of PharmHouse ‘s stake and the flagship aims to start the cultivation operations at its facility over 190,000 sq. feet of a licensed nursery infrastructure. The company is expecting to cultivate all of the available 1.3 million square feet by the year end. 

Apparently, Mastronardi Produce limited is another party that is involved in the joint venture, which is also a conglomerate of operators and principals of North American agriculture and produce.

For the record, Leamington, PharmHouse’s greenhouse facility in Ontario that the Canopy Rivers has helped in financing, building and facilitating the license application, is reportedly one of the largest in the world that uses an extremely high degree of lean manufacturing and automation process inspired  by the best practices of commercial agriculture.

PharmHouse’s General Manager, Tony Abbas said that the company, since its inception, has focused on speed, capacity and innovation that has always been its competitive advantage. The company’s focused and strong team aims to continue with their fast progress and ramp up their operations in the forthcoming months now that it has the license in hand with a fully funded project.

PharmHouse is well on its way to establishing the company as a premier low-cost, large-scale global cannabis distribution and production platform, Abbas continued.  

Paul Mastronardi, Mastronardi Produce Limited’s CEO commented about the license being a monumental achievement for the joint venture, PharmHouse, that represents the future of cannabis distribution, production and technological innovation.

The company looks forward to continuing lending their proven marketing, operational and distribution expertise to PharmHouse as well as partnering with Canopy Rivers to keep building the company’s planned global cannabis platform, Mastronardi added.

 

Source credit-

 https://www.prnewswire.com/news-releases/canopy-rivers-flagship-pharmhouse-jv-licensed-by-health-canada-300888383.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

Microsoft investigates Teams and Outlook outage that left users disrupted

Microsoft investigates Teams and Outlook outage that left users disrupted

By Mateen Dalal

Microsoft, the U.S.-based technology frontrunner, reportedly investigating an outage that prevented thousands of customers from accessing services like Teams and Outlook. Apparently, the tech giant did not disclose the number of users that were im...

UK: Budget & basic items’ cost in supermarkets soar 20.3% in December

UK: Budget & basic items’ cost in supermarkets soar 20.3% in December

By Mateen Dalal

Britishers who rely on the budget-friendly aisles of supermarkets reportedly saw the biggest increases in food prices in the months leading up to Christmas, significantly outpacing those for luxury as well as premium brands, as per a survey. Accor...

Sun Cable shuts as $21B solar project to power S’pore hangs in balance

Sun Cable shuts as $21B solar project to power S’pore hangs in balance

By Mateen Dalal

Sun Cable, the Singapore-based solar energy company, has reportedly entered voluntary administration, despite the financial support it received from billionaire investors. The company was supposed to be working on a A$30 billion (US$21 billion) solar...